AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28641030 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg E4 combined with 150 μg LNG
Number of subjects: 396
Study 28641030 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg E4 combined with 150 μg LNG
Number of subjects: 396
Study 28641030 — intervention group
Group type: COMPARATOR
Intervention: E2V combined with DNG
Number of subjects: 396
Study 23904178 — intervention group
Group type: EXPERIMENTAL
Intervention: Drawing and telling about their presenting problem
Number of subjects: 33
Study 23904178 — intervention group
Group type: COMPARATOR
Intervention: Telling only
Number of subjects: 33
Study 23748252 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (75 mg twice per day) and celecoxib (100 mg twice per day) for 14 days before THA and for three weeks after discharge.
Number of subjects: 0
Study 23748252 — intervention group
Group type: COMPARATOR
Intervention: Placebo for the same duration as the intervention group.
Number of subjects: 0
Study 21426884 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,600 mg of MESNA plus 0.9% saline
Number of subjects: 100
Study 21426884 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus 0.9% saline
Number of subjects: 100
Study 21426884 — intervention group
Group type: EXPERIMENTAL
Intervention: MESNA
Number of subjects: 100
Study 21426884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 20052918 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycloferon addition to main therapy
Number of subjects: 0
Study 20052918 — intervention group
Group type: COMPARATOR
Intervention: Main therapy without cycloferon
Number of subjects: 0
Study 18411913 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy (HRT)
Number of subjects: 65
Study 18411913 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal supplement therapy per oss (HST)
Number of subjects: 65
Study 18411913 — intervention group
Group type: COMPARATOR
Intervention: Transdermal placebo (Control)
Number of subjects: 65
Study 15132876 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxybenzamine-hydrochloride: 10 mg two times a day for one month
Number of subjects: 45
Study 15132876 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavoxate HCI-neptumus: 200 mg three times a day for one month
Number of subjects: 45
Study 15132876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 10678582 — intervention group
Group type: EXPERIMENTAL
Intervention: PathVysion HER‐2 fluorescence in situ hybridization (FISH) assay
Number of subjects: 4
Study 10678582 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of 20 nuclei
Number of subjects: 4
Study 9071894 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life assessment in clinical trials
Number of subjects: 0
Study 9071894 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods for improving compliance in QoL assessments
Number of subjects: 0
Study 8444626 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking education program
Number of subjects: 0
Study 2417579 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral scatter argon laser photocoagulation
Number of subjects: 401
Study 31322116 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g intravenous bolus followed by an 8‐hour 1‐g infusion)
Number of subjects: 2325
Study 31322116 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 2325
Study 31322116 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 2325
Study 29843449 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning labels (WLs)
Number of subjects: 1607
Study 29843449 — intervention group
Group type: COMPARATOR
Intervention: Traffic-Light labels (TLLs)
Number of subjects: 1607
Study 27928115 — intervention group
Group type: EXPERIMENTAL
Intervention: PSG (pre‐germinated brown rice bran extract)
Number of subjects: 60
Study 27928115 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 60
Study 22530793 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh-frozen bone blocks
Number of subjects: 24
Study 22530793 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone blocks
Number of subjects: 24
Study 22526405 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 31
Study 22526405 — intervention group
Group type: COMPARATOR
Intervention: Brief supportive psychotherapy (BSP)
Number of subjects: 31
Study 20197354 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine treatment for 4 months
Number of subjects: 34
Study 20197354 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment for 4 months
Number of subjects: 34
Study 20197354 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine treatment after conventional therapy
Number of subjects: 34
Study 20197354 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment after telemedicine therapy
Number of subjects: 34
Study 20197354 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall service delivery
Number of subjects: 34
Study 19347813 — intervention group
Group type: EXPERIMENTAL
Intervention: CD36 expression on monocytes in obese women (mean 62.99 ± 18.07)
Number of subjects: 30
Study 19347813 — intervention group
Group type: COMPARATOR
Intervention: CD36 expression on monocytes in nonobese women (mean 82.5 ± 22.93)
Number of subjects: 30
Study 19347813 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass, BMI, WHR, waist and hip circumferences in obese women
Number of subjects: 30
Study 19347813 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose and insulin concentrations in 0', 30', 60' of OGTT in obese women
Number of subjects: 30
Study 19347813 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMA and FIRI values in obese women
Number of subjects: 30
Study 15996385 — intervention group
Group type: EXPERIMENTAL
Intervention: New surgical technique using acellular dermal matrix graft (ADMG)
Number of subjects: 32
Study 15996385 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique using acellular dermal matrix graft (ADMG)
Number of subjects: 32
Study 12050268 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF‐I (30 microg/kg sc twice daily) and oral contraceptive (Ovcon 35, 35 microg ethinyl estradiol and 0.4 mg norethindrone)
Number of subjects: 60
Study 12050268 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF‐I alone (30 microg/kg sc twice daily)
Number of subjects: 60
Study 12050268 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive alone
Number of subjects: 60
Study 12050268 — intervention group
Group type: COMPARATOR
Intervention: No active therapy
Number of subjects: 60
Study 10968690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10968690 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 microg GM-CSF
Number of subjects: 30
Study 10968690 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 microg GM-CSF
Number of subjects: 30
Study 8623971 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine (NG)
Number of subjects: 27
Study 8623971 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine and IV N‐butyl‐scopolamine (NSG)
Number of subjects: 27
Study 8623971 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 27
Study 1375685 — intervention group
Group type: EXPERIMENTAL
Intervention: Anistreplase (doses ranging from 3.75 to 35 IU, 60% received 30 IU)
Number of subjects: 424
Study 1375685 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay from onset of symptoms to treatment
Number of subjects: 424
Study 3970454 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 14
Study 3970454 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 14
Study 31155559 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC‐ODT
Number of subjects: 13
Study 31155559 — intervention group
Group type: COMPARATOR
Intervention: IC‐ODTs
Number of subjects: 13
Study 29111863 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise intervention (jumping rope, 75 min/session, 3 sessions/week for 12 weeks)
Number of subjects: 75
Study 29111863 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise intervention
Number of subjects: 75
Study 29111863 — intervention group
Group type: COMPARATOR
Intervention: Reading control group
Number of subjects: 75
Study 25985403 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral tenofovir (PrEP)
Number of subjects: 2413
Study 23238930 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (TR)
Number of subjects: 50
Study 23238930 — intervention group
Group type: COMPARATOR
Intervention: Control group (CO)
Number of subjects: 50
Study 21343755 — intervention group
Group type: COMPARATOR
Intervention: MVI 100
Number of subjects: 374
Study 21343755 — intervention group
Group type: EXPERIMENTAL
Intervention: MVI 200
Number of subjects: 374
Study 19594663 — intervention group
Group type: EXPERIMENTAL
Intervention: CTG
Number of subjects: 40
Study 19594663 — intervention group
Group type: COMPARATOR
Intervention: CTG+R
Number of subjects: 40
Study 16562387 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA (patient controlled epidural analgesia)
Number of subjects: 0
Study 16562387 — intervention group
Group type: COMPARATOR
Intervention: PCA (peripheral patient controlled analgesia)
Number of subjects: 0
Study 12598483 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (12 subjects) - supine cycle ergometry at 75% of pre-bed rest heart rate maximum for 90 min/day during HDT bed rest
Number of subjects: 20
Study 12598483 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise group (8 subjects)
Number of subjects: 20
Study 11508561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive in-home interventions
Number of subjects: 238
Study 11508561 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 238
Study 9207870 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary dissection prepared by liposuction (Suzanne's procedure)
Number of subjects: 200
Study 9207870 — intervention group
Group type: COMPARATOR
Intervention: Functional lymphadenectomy by classical dissection
Number of subjects: 200
Study 9207870 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical mastectomy
Number of subjects: 200
Study 9207870 — intervention group
Group type: COMPARATOR
Intervention: Total mastectomy
Number of subjects: 200
Study 7962030 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented femoral stem
Number of subjects: 60
Study 7962030 — intervention group
Group type: EXPERIMENTAL
Intervention: Porous-coated femoral stem
Number of subjects: 60
Study 7962030 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coated femoral stem
Number of subjects: 60
Study 7962030 — intervention group
Group type: COMPARATOR
Intervention: All groups (Cemented, Hydroxyapatite-coated, Porous-coated)
Number of subjects: 60
Study 3455212 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treatment (ST)
Number of subjects: 38
Study 3455212 — intervention group
Group type: COMPARATOR
Intervention: Non-steroid treatment (NT)
Number of subjects: 38
Study 2115754 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of triage criteria by private practitioners during intervention months
Number of subjects: 404
Study 30414289 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased serum galectin-3 in hyperglycemic patients
Number of subjects: 3082
Study 28491474 — intervention group
Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 62
Study 28491474 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher self-efficacy scores for healthy eating
Number of subjects: 62
Study 28491474 — intervention group
Group type: COMPARATOR
Intervention: Racial subgroups
Number of subjects: 62
Study 25495610 — intervention group
Group type: EXPERIMENTAL
Intervention: ICAM-1 at 1 month
Number of subjects: 803
Study 25495610 — intervention group
Group type: EXPERIMENTAL
Intervention: ICAM-1 at 6 months
Number of subjects: 803
Study 25495610 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 at 6 months
Number of subjects: 803
Study 25495610 — intervention group
Group type: EXPERIMENTAL
Intervention: ICAM-1 trajectory
Number of subjects: 803
Study 25495610 — intervention group
Group type: EXPERIMENTAL
Intervention: ICAM-1 and IL-10
Number of subjects: 803
Study 25495610 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP levels at 1 month
Number of subjects: 803
Study 25495610 — intervention group
Group type: EXPERIMENTAL
Intervention: ICAM-1 levels at baseline, 1 month and 6 months
Number of subjects: 803
Study 25495610 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 levels at 1 month and 6 months
Number of subjects: 803
Study 25495610 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 levels at 6 months
Number of subjects: 803
Study 24047926 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes self-management education intervention
Number of subjects: 252
Study 24047926 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control
Number of subjects: 252
Study 21808863 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobalt-chromium stents
Number of subjects: 187
Study 21808863 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel stents
Number of subjects: 187
Study 17914031 — intervention group
Group type: EXPERIMENTAL
Intervention: rs17880135 in the 3' region of superoxide dismutase 1 (SOD1)
Number of subjects: 1362
Study 17914031 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional SOD1 variants (rs202446, rs9974610, rs204732)
Number of subjects: 1362
Study 17914031 — intervention group
Group type: EXPERIMENTAL
Intervention: rs17880135 and rs17881180
Number of subjects: 1362
Study 16814890 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented millet drink (KSW) 300 ml daily for 5 days
Number of subjects: 184
Study 16814890 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for diarrhoea at local clinic
Number of subjects: 184
Study 16027693 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nasogastric feeding
Number of subjects: 70
Study 16027693 — intervention group
Group type: COMPARATOR
Intervention: Intermittent nasogastric feeding
Number of subjects: 70
Study 16027693 — intervention group
Group type: COMPARATOR
Intervention: Intermittent orogastric feeding
Number of subjects: 70
Study 11176557 — intervention group
Group type: EXPERIMENTAL
Intervention: $5 cash incentive
Number of subjects: 873
Study 11176557 — intervention group
Group type: EXPERIMENTAL
Intervention: $10 cash incentive
Number of subjects: 873
Study 11176557 — intervention group
Group type: EXPERIMENTAL
Intervention: $20 cash incentive
Number of subjects: 873
Study 11176557 — intervention group
Group type: COMPARATOR
Intervention: Control (no incentive)
Number of subjects: 873
Study 9274231 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased parental involvement in post-operative care through information and education.
Number of subjects: 0
Study 9274231 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study 7944428 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent infusion of ADM or MMC
Number of subjects: 57
Study 7944428 — intervention group
Group type: COMPARATOR
Intervention: No regional chemotherapy
Number of subjects: 57
Study 7944428 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of 5-FU
Number of subjects: 57
Study 7944428 — intervention group
Group type: COMPARATOR
Intervention: No local chemotherapy
Number of subjects: 57
Study 3232498 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 20 mg I.M.
Number of subjects: 60
Study 3232498 — intervention group
Group type: COMPARATOR
Intervention: Pentazocine 30 mg I.M.
Number of subjects: 60
Study 29705231 — intervention group
Group type: EXPERIMENTAL
Intervention: Microvascular Decompression (MVD)
Number of subjects: 441
Study 29705231 — intervention group
Group type: COMPARATOR
Intervention: Gamma Knife Surgery (GKS)
Number of subjects: 441
Study 29705231 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MVD and GKS
Number of subjects: 441
Study 29919984 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT)
Number of subjects: 73
Study 25276627 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (1g)
Number of subjects: 80
Study 25276627 — intervention group
Group type: COMPARATOR
Intervention: Placebo (iv)
Number of subjects: 80
Study 22541055 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)‐rich oil
Number of subjects: 90
Study 22541055 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)‐rich oil
Number of subjects: 90
Study 22541055 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil (control)
Number of subjects: 90
Study 22541055 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased erythrocyte DHA
Number of subjects: 90
Study 22541055 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased erythrocyte DHA in subgroup of 17 children with learning difficulties
Number of subjects: 90
Study 20822500 — intervention group
Group type: EXPERIMENTAL
Intervention: 225 mg of polaprezinc in addition to standard therapies
Number of subjects: 79
Study 20822500 — intervention group
Group type: COMPARATOR
Intervention: Standard therapies only
Number of subjects: 79
Study 19082232 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ultrasonic dissector (US)
Number of subjects: 528
Study 19082232 — intervention group
Group type: COMPARATOR
Intervention: Laser
Number of subjects: 528
Study 16907767 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement-retained crowns
Number of subjects: 80
Study 16907767 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw-retained crowns
Number of subjects: 80
Study 16907767 — intervention group
Group type: COMPARATOR
Intervention: Both crown types
Number of subjects: 80
Study 16907767 — intervention group
Group type: COMPARATOR
Intervention: Esthetic fulfillment survey
Number of subjects: 80
Study 12794385 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic susceptibility testing
Number of subjects: 206
Study 11252222 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and feedback, consensus building, reminder system
Number of subjects: 54
Study 8982878 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual/mechanical compression technique
Number of subjects: 0
Study 8982878 — intervention group
Group type: COMPARATOR
Intervention: Mechanical compression technique
Number of subjects: 0
Study 7520857 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention (specifics not provided)
Number of subjects: 0
Study 7520857 — intervention group
Group type: EXPERIMENTAL
Intervention: Appetite stimulants (specifics not provided)
Number of subjects: 0
Study 7520857 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral and parenteral alimentation (under evaluation)
Number of subjects: 0
Study 3608051 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5 percent
Number of subjects: 100
Study 3608051 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1 percent
Number of subjects: 100
Study 3608051 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 100
Study 3608051 — intervention group
Group type: COMPARATOR
Intervention: No injection (Control)
Number of subjects: 100
Study 31829427 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention (in-service training, mentorship, supportive supervision, and infrastructure support)
Number of subjects: 784
Study 31829427 — intervention group
Group type: COMPARATOR
Intervention: Control group (12 facilities)
Number of subjects: 784
Study 31829427 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention (high implementation)
Number of subjects: 784
Study 30793700 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural approaches (RAFT) plus usual care (Arthritis Research UK fatigue booklet)
Number of subjects: 333
Study 28050704 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowing action immediately before intravenous fentanyl (S group)
Number of subjects: 0
Study 28050704 — intervention group
Group type: COMPARATOR
Intervention: No swallowing action (non-S group)
Number of subjects: 0
Study 25855501 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser setting at 140 nJ (spot distance 3.0 µm)
Number of subjects: 22
Study 25855501 — intervention group
Group type: COMPARATOR
Intervention: Femtosecond laser setting at 170 nJ (spot distance 4.5 µm)
Number of subjects: 22
Study 23774096 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive video-assisted thyroidectomy (MIVAT)
Number of subjects: 224
Study 23774096 — intervention group
Group type: COMPARATOR
Intervention: Conventional thyroidectomy (CT)
Number of subjects: 224
Study 21500582 — intervention group
Group type: EXPERIMENTAL
Intervention: Kyphoplasty
Number of subjects: 60
Study 21500582 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (Control)
Number of subjects: 60
Study 19674724 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum limit statements (e.g., maximum distances, maximum durations, maximum prices, maximum delivery times)
Number of subjects: 3
Study 19674724 — intervention group
Group type: EXPERIMENTAL
Intervention: Mistaken maxima
Number of subjects: 3
Study 19674724 — intervention group
Group type: COMPARATOR
Intervention: Information preferences
Number of subjects: 3
Study 17344008 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachytherapy with Ir-192 (mean dose 30 Gy) and external radiotherapy (mean dose 50 Gy)
Number of subjects: 21
Study 17344008 — intervention group
Group type: COMPARATOR
Intervention: Stent insertion only
Number of subjects: 21
Study 17344008 — intervention group
Group type: COMPARATOR
Intervention: Stent insertion and brachytherapy only (control group of 8 patients)
Number of subjects: 21
Study 15547164 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized physician standing orders
Number of subjects: 3777
Study 15547164 — intervention group
Group type: COMPARATOR
Intervention: Computerized physician reminders
Number of subjects: 3777
Study 11303344 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-reflux treatment in reflux positive HRAD patients
Number of subjects: 107
Study 11303344 — intervention group
Group type: COMPARATOR
Intervention: No treatment for reflux in reflux negative HRAD patients
Number of subjects: 107
Study 11303344 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients with apnea
Number of subjects: 107